GT Biopharma (GTBP) had the best year between 2011 and 2020 by a US stock in 2012, returning 3,044,698,370%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Heritage Global (HGBL) | 2011 | 1,400% |
Versus Systems Inc. (VS) | 2011 | 1,473% |
InnovAge (INNV) | 2011 | 2,566.67% |
Sequans Communications (SQNS) | 2011 | 3,349,297.59% |
Castellum (CTM) | 2011 | 6,521,639.13% |
INVO Fertility (IVF) | 2012 | 314,081.93% |
GT Biopharma (GTBP) | 2012 | 3,044,698,370% |
Versus Systems Inc. (VS) | 2012 | 163,639.24% |
QXO (QXO) | 2012 | 1,151,950% |
Nixxy (NIXX) | 2012 | 64,900% |
Canadian Solar (CSIQ) | 2013 | 752% |
NextTrip (NTRP) | 2013 | 1,175.86% |
Aurinia Pharmaceuticals (AUPH) | 2013 | 5,088.91% |
Nutex Health (NUTX) | 2013 | 749,900.2% |
Almonty Industries Inc Common Shares (ALM) | 2013 | 849.8% |
Processa Pharmaceuticals (PCSA) | 2014 | 1,796,566.67% |
Akari Therapeutics (AKTX) | 2014 | 2,704,125.35% |
Ainos (AIMD) | 2014 | 2,057.89% |
TCTM Kids IT Education (VSA) | 2014 | 348,985.31% |
Aurora Cannabis (ACB) | 2014 | 1,403,950.67% |
GT Biopharma (GTBP) | 2015 | 9,042.86% |
Eastside Distilling (BLNE) | 2015 | 7,995.95% |
SurgePays (SURG) | 2015 | 4,400% |
Cidara Therapeutics (CDTX) | 2015 | 2,045% |
LM Funding America (LMFA) | 2015 | 8,979,697.98% |
